Literature DB >> 3209584

Procoagulant activity of mouse transformed cells: different expression in freshly isolated or cultured cells.

L Curatolo1, M G Alessio, B Casali, A Falanga, M B Donati, N Semeraro.   

Abstract

This study was originally designed to investigate whether there is any correlation between the type of procoagulant activity (PCA) and the tumorigenicity of transformed cells. The data obtained are relevant to this question and to defining the differences in the expression of cellular activities depending on the in vitro system used. PCA was measured and characterized in normal, immortalized, and tumorigenic mouse fibroblasts. In all the cell lines studied the activity was of tissue factor type, as established with functional, enzymatic, and immunochemical criteria. However, the PCA of cells freshly isolated from the tumors induced by tumorigenic cell lines was of cancer procoagulant type, i.e. a cysteine protease with direct factor X activator activity. The same cells, when cultured in vitro, expressed again PCA of tissue-factor type. These results suggest that either a tumor-host interaction is required for the expression of cancer procoagulant or the latter activity, produced by tumor cells under in vitro conditions, is destroyed or inactivated during the culture period. Our findings caution against defining the procoagulant activity of tumors based on experiments on cultured cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3209584     DOI: 10.1007/bf02624183

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol        ISSN: 0883-8364


  12 in total

1.  Characterization of transformed cell lines evolving from a normal C3H line.

Authors:  L Curatolo; G Frascotti; P Ubezio; C Mannironi; L Morasca
Journal:  Exp Cell Biol       Date:  1988

2.  Comparison of properties of cancer procoagulant and human amnion-chorion procoagulant.

Authors:  A Falanga; S G Gordon
Journal:  Biochim Biophys Acta       Date:  1985-09-20

Review 3.  Malignancy and haemostasis.

Authors:  M B Donati; A Poggi
Journal:  Br J Haematol       Date:  1980-02       Impact factor: 6.998

4.  Fibrin clot retractile activity of mouse fibroblasts during growth and aging.

Authors:  L Curatolo; G Balconi; R Borgia; L Morasca; M B Donati
Journal:  In Vitro       Date:  1980-09

5.  Cancer procoagulant in human tumor cells: evidence from melanoma patients.

Authors:  M B Donati; C Gambacorti-Passerini; B Casali; A Falanga; P Vannotti; G Fossati; N Semeraro; S G Gordon
Journal:  Cancer Res       Date:  1986-12       Impact factor: 12.701

6.  Procoagulant activity of mouse and human cultured cells following various types of transformation.

Authors:  L Curatolo; G Alessio; C Gambacorti Passerini; B Casali; L Morasca; N Semeraro; M B Donati
Journal:  Int J Cancer       Date:  1985-03-15       Impact factor: 7.396

7.  Extracellular cysteine proteinase and collagenase activities as a consequence of tumor-host interaction in the rabbit V2 carcinoma.

Authors:  A Baici; M Gyger-Marazzi; P Sträuli
Journal:  Invasion Metastasis       Date:  1984

8.  Culture conditions induce the appearance of immortalized C3H mouse cell lines.

Authors:  L Curatolo; E Erba; L Morasca
Journal:  In Vitro       Date:  1984-08

Review 9.  Fibrin as a component of the tumor stroma: origins and biological significance.

Authors:  H F Dvorak; D R Senger; A M Dvorak
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

Review 10.  Cancer cell procoagulants and their pharmacological modulation.

Authors:  M B Donati; N Semeraro
Journal:  Haemostasis       Date:  1984
View more
  1 in total

Review 1.  Non-tissue factor procoagulants in cancer cells.

Authors:  S G Gordon; M Chelladurai
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.